David M. Livingston

Charles A. Dana Chair in Human Cancer Genetics at Dana-Farber Cancer Institute, Inc.

David M. Livingston

David M. Livingston

Charles A. Dana Chair in Human Cancer Genetics at Dana-Farber Cancer Institute, Inc.

Overview
RelSci Relationships

4768

Number of Boards

6

Relationships
RelSci Relationships are individuals David M. Livingston likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Cedilla Therapeutics, Inc.

Relationship likelihood: Strong

Scientific Founder at Blueprint Medicines Corp.

Relationship likelihood: Strong

President, Chief Executive Officer & Trustee at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Director at The Tisch Cancer Institute - Icahn School of Medicine at Mount Sinai

Relationship likelihood: Strong

Member & Head, Program in Immunology, Clinical Research Division at Fred Hutchinson Cancer Research Center

Relationship likelihood: Strong

Editor-in-Chief at The Oncologist

Relationship likelihood: Strong

Rebecca C. Lancefield Professor in Mammalian Cell Biology & Development at The Rockefeller University

Relationship likelihood: Strong

Founder at Jounce Therapeutics, Inc.

Relationship likelihood: Strong

Director, Founding Core Institute Member at The Broad Institute, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Paths to David M. Livingston
Potential Connections via
Relationship Science
You
David M. Livingston
Charles A. Dana Chair in Human Cancer Genetics at Dana-Farber Cancer Institute, Inc.
Education
MD, magna cum laude
Class of 1965

Tufts University School of Medicine is an international leader in innovative medical education and advanced research. The School of Medicine is renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level.

Class of 1965

THE ORGANIZATION'S PURPOSE IS TO PROVIDE SERVICES AND PROMOTE FELLOWSHIP AMONG ITS MEMBERS. THE ORGANIZATION SHALL RAISE FUNDS TO PROVIDE "MARGIN OF EXCELLENCE" SUPPORT FOR THE CORPS OF CADETS (PRESENT DAY STUDENTS) AS COAST GUARD OFFICERS AND CIVILIAN EXMPLOYEES ARE PROHIBITED BY THE LAW FROM SEEKING FUNDS BEYOND WHAT IS APPROPRIATED BY CONGRESS. THE ASSOCIATION IS A 501(C)(3) AND ALSO SERVES TO PRESERVE TRADITIONS AND ENHANCE THE REPUTATION OF THE ACADEMY AS IT CARRIES OUT THE ABOVE FUNCTIONS.

AB, cum laude
Class of 1961

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Memberships
Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

Founded in 1780, the American Academy of Arts and Sciences is an independent policy research center that conducts multidisciplinary studies of complex and emerging problems. The Academy’s elected members are leaders in the academic disciplines, the arts, business, and public affairs. With a current membership of 4,000 American Fellows and 600 Foreign Honorary Members, the Academy has four major goals: Promoting service and study through analysis of critical social and intellectual issues and the development of practical policy alternatives; Fostering public engagement and the exchange of ideas with meetings, conferences, and symposia bringing diverse perspectives to the examination of issues of common concern; Mentoring a new generation of scholars and thinkers through the Visiting Scholars Program and Hellman Fellowship Program; Honoring excellence by electing to membership men and women in a broad range of disciplines and professions. Click here to learn about our new members. The Academy's headquarters are in Cambridge, Massachusetts. With its geographically diverse membership, it conducts activities in this country and abroad

Member
Current

American Society for Clinical Investigation is an American private company located in Ann Arbor, MI, that provides clinical investigation services.

Career History
Charles A. Dana Chair in Human Cancer Genetics
Current

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

Emil Frei Distinguished Professor of Medicine, Department of Genetics
Current

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Science Partner
Current

Nextech is an active manager which invests in oncology companies located in Europe and the US with investments from company inceptions to crossover rounds. The firm seeks to invest in well managed companies with proprietary, cutting-edge products which understand the market and their competitors. The investment approach aims to take drug assets in the preclinical stage and build their value by demonstrating clinical efficacy. Nextech mainly acts as a lead investor in Europe and co-invests in OECD countries outside of Europe. The firm makes investments based on recommendations from their Scientific Advisory Board, which assesses the scientific concept and the drug development plan. The firm aims to exit their investments through trade sales and IPOs after demonstrating efficacy or comparable benefits in human studies.

Boards & Committees
Member, Scientific Advisory Board
Current

Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA.

Chairman, Exclusive Scientific Advisory Board
Prior - 2014

Nextech is an active manager which invests in oncology companies located in Europe and the US with investments from company inceptions to crossover rounds. The firm seeks to invest in well managed companies with proprietary, cutting-edge products which understand the market and their competitors. The investment approach aims to take drug assets in the preclinical stage and build their value by demonstrating clinical efficacy. Nextech mainly acts as a lead investor in Europe and co-invests in OECD countries outside of Europe. The firm makes investments based on recommendations from their Scientific Advisory Board, which assesses the scientific concept and the drug development plan. The firm aims to exit their investments through trade sales and IPOs after demonstrating efficacy or comparable benefits in human studies.

Member, Board of Directors
Current

The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY.

Member, International Scientific Advisory Board
Current

Istituto Europeo di Oncologia Srl is a holding company, which operates oncology hospitals. It offers healthcare services, basic and translational cancer research, and PhD and post doctoral programs in molecular medicine. The company was founded by Umberto Veronesi on May 30, 1994 and is headquartered in Milan, Italy.

Chairman, Executive Committee for Research
1996 - 2000

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$250 - $999
2017

THE ORGANIZATION'S PURPOSE IS TO PROVIDE SERVICES AND PROMOTE FELLOWSHIP AMONG ITS MEMBERS. THE ORGANIZATION SHALL RAISE FUNDS TO PROVIDE "MARGIN OF EXCELLENCE" SUPPORT FOR THE CORPS OF CADETS (PRESENT DAY STUDENTS) AS COAST GUARD OFFICERS AND CIVILIAN EXMPLOYEES ARE PROHIBITED BY THE LAW FROM SEEKING FUNDS BEYOND WHAT IS APPROPRIATED BY CONGRESS. THE ASSOCIATION IS A 501(C)(3) AND ALSO SERVES TO PRESERVE TRADITIONS AND ENHANCE THE REPUTATION OF THE ACADEMY AS IT CARRIES OUT THE ABOVE FUNCTIONS.

$50K +
2017

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

$5,000 - $10K
2017

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Political Donations
$2,500
2012

Former President of United States

$500
2010

Former Governor of Massachusetts

$2,300
2008

Former President of United States

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David M. Livingston. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David M. Livingston's profile does not indicate a business or promotional relationship of any kind between RelSci and David M. Livingston.